← Leaderboards
Kaleen Nicole Hayes
Brown University
$3,687,727
Attributed
$7,375,453
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.2M · FY2022–25$5M$3.8M$2.5M$1.3M$0
'22
'23
'24
'25
Funding mix
By agency
NIH$7,375,453 · 3
By mechanism
RF1$4,850,333 · 2
R01$2,525,120 · 1
Top collaborators
- Suzanne Cadarette5 shared
- Daniel Harris1 shared
- Andrew Reis Zullo1 shared
Most similar at Brown University
Same institution · by research overlap
- Maricruz Rivera-Hernandez$4,037,202
- Suzanne Cadarette$1,262,560
- Terrie F Wetle$3,455,767
- Vincent Mor$57,855,506
- Hye-Young Jung$4,220,524
Others in their field
Other Rising Stars on “Characteristics”
- Jeffrey Leintz · National Opinion Research Center$40,628,545
- Supriya Menezes · The Emmes Company, Llc$18,394,958
- Eric Anderson · Columbia University Health Sciences$11,474,975
- Benjamin M Greenberg · Ut Southwestern Medical Center$11,474,975
- Jinsy Andrews · Columbia University Health Sciences$11,474,975
- Alanna Maguire · Mayo Clinic Rochester$9,942,431
Research focus
CharacteristicsNursing HomesSubgroupClinical AssessmentsPharmaceutical PreparationsMedicare ClaimHigh RiskPharmacoepidemiologyElectronic Health RecordFutureNational Institute On AgingAdverse EventLinkMedicareData SetFrailtyJointsDrug UsageLife ExpectancyGuidelinesData SourcesHarm ReductionCessation Of LifeExposure To
Grant awards (7)
Benefits and Harms of Antihypertensive Management Strategies for Nursing Home Residents with ADRD$2,612,229
RF1 · FY2025 · AG
Benefits and Harms of Long-term Osteoporosis Pharmacotherapy: Impact of Treatment Length, Type, Switching, and Holidays$476,397
R01 · FY2025 · AG · contact PI
Benefits and Harms of Long-term Osteoporosis Pharmacotherapy: Impact of Treatment Length, Type, Switching, and Holidays$138,134
R01 · FY2025 · AG · contact PI
Prescribing Cascades among Nursing Home Residents with ADRD$2,238,104
RF1 · FY2024 · AG
Benefits and Harms of Long-term Osteoporosis Pharmacotherapy: Impact of Treatment Length, Type, Switching, and Holidays$638,256
R01 · FY2024 · AG · contact PI
Benefits and Harms of Long-term Osteoporosis Pharmacotherapy: Impact of Treatment Length, Type, Switching, and Holidays$635,331
R01 · FY2023 · AG · contact PI
Benefits and Harms of Long-term Osteoporosis Pharmacotherapy: Impact of Treatment Length, Type, Switching, and Holidays$637,002
R01 · FY2022 · AG · contact PI